A Study Of Chemotherapy Using A Functional Precision Assay In Surgical Resection Of Pancreatic Ductal Adenocarcinoma (PDAC)
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Scottsdale/Phoenix, Arizona: 26-002011
About this study
The purpose of this study is to assess the logistical feasibility of performing phenotypic-driven functional precision medicine chemosensitivity report on surgically-resected PDAC specimens shipped to KYAN Technologies’s facilities at Mayo Lab Services (Rochester, MN).
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Histologically proven pancreatic adenocarcinoma
AJCC (8th edition) Stage I-III
Surgically resectable disease according to NCCN criteria (Version 1.2023 - May 4, 2023)
Anticipated surgical resection at Mayo Clinic, Arizona
Age > 18 years
Ability to provide informed consent
Exclusion Criteria:
Pancreatic histology other than ductal adenocarcinoma
Serious medical comorbidities or other contraindications to surgery
Prior malignancy within 5 years treated with chemotherapy
Radiologic complete response to neoadjuvant chemotherapy for primary pancreatic ductal adenocarcinoma (predicted insufficient tissue for research specimen)
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 05/27/2026. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Richard Bold, M.D., M.B.A. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available